- Home
- HRTX vs SRV Comparison
HRTX vs SRV Comparison
Compare HRTX & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- SRV
- Stock Information
- Founded
- HRTX 1983
- SRV 2007
- Country
- HRTX United States
- SRV United States
- Employees
- HRTX N/A
- SRV N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- SRV Finance Companies
- Sector
- HRTX Health Care
- SRV Finance
- Exchange
- HRTX Nasdaq
- SRV Nasdaq
- Market Cap
- HRTX 206.9M
- SRV 195.1M
- IPO Year
- HRTX 1987
- SRV N/A
- Fundamental
- Price
- HRTX $1.21
- SRV $44.73
- Analyst Decision
- HRTX Strong Buy
- SRV
- Analyst Count
- HRTX 2
- SRV 0
- Target Price
- HRTX $4.50
- SRV N/A
- AVG Volume (30 Days)
- HRTX 1.4M
- SRV 33.9K
- Earning Date
- HRTX 11-11-2025
- SRV 01-01-0001
- Dividend Yield
- HRTX N/A
- SRV 13.38%
- EPS Growth
- HRTX N/A
- SRV N/A
- EPS
- HRTX N/A
- SRV N/A
- Revenue
- HRTX $149,694,000.00
- SRV N/A
- Revenue This Year
- HRTX $10.62
- SRV N/A
- Revenue Next Year
- HRTX $12.99
- SRV N/A
- P/E Ratio
- HRTX N/A
- SRV N/A
- Revenue Growth
- HRTX 9.78
- SRV N/A
- 52 Week Low
- HRTX $1.04
- SRV $30.73
- 52 Week High
- HRTX $2.68
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- HRTX 28.21
- SRV 65.93
- Support Level
- HRTX $1.25
- SRV $44.42
- Resistance Level
- HRTX $1.27
- SRV $45.24
- Average True Range (ATR)
- HRTX 0.06
- SRV 0.58
- MACD
- HRTX 0.01
- SRV 0.12
- Stochastic Oscillator
- HRTX 8.70
- SRV 72.88
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.